Ovulation Disorders Flashcards
erectile dysfunction in overweight men
oestrogen plays a role in fat storing and is naturally present in small amounts in men, when you gain weight, oestrogen levels rise
this inhibits GnRH production and testosterone
results in erectile dysfunction etc
what is the rate limiting step for the production of steroids
the conversion of cholesterol to pregnenolone
synthesis of progesterone
synthesised from pregnenolone by the action of 3ß-HSD in the corpus luteum, by the placenta during pregnancy and by the adrenals (as a step in the androgen and mineralocorticoid synthesis)
oligomenorrhoea
reduction in frequency of periods to less than 9 a year
primary amenorrhoea
failure of menarche by the age of 16
think anatomical/congenital (Turner’s/Kallmann) cause?
secondary amenorrhoea
cessation of periods for >6 months in an individual who has previously menstruated
physiological causes of amenorrhoea
pregnancy
post menopause
causes of secondary amenorrhoea
Ovarian problem: PCOS, premature ovarian failure
Uterine problem: uterine adhesions
Hypothalamic dysfunction: weight loss (BMI <18.5), over exercise, stress, infiltrative
Pituitary: high PRL, hypopituitarism
symptoms of oestrogen deficiency
flushing, libido, breast tenderness, vaginal atrophy causing dyspareunia (painful sex)
vaginal atrophy
inflammation of the vagina due to thinning and shrinking of the tissue
can be due to oestrogen deficinecy
investigations of amenorrhoea
LH, FSH, Oestradiol (main oestrogen)
ovarian US ± endometrial thickness
testosterone if there is hirsutism
pituitary function tests and MRI pituitary if indicated
karotype if it is primary amenorrhoea/Turner’s symptoms
what is female hypogonadism identified by
low levels of oestrogen
primary hypogonadism
problem with ovaries - high FH/LSH = hypergonadotrophic hypogonadism
eg premature ovarian failure
secondary hypogonadism
problem with the hyothalamus/pituitary axis - low LH/FSH = hypogonadotrophic hypogonadism
WHO group 1 definition of anovulation
hypothalamic pituitary failure
- low LSH, FH, oestrogen deficiency, normal PRL, amenorrhoea
progesterone challenge test
used to evaluate a patient who is experiencing amenorrhoea
progesterone administered as an IM injection
if the patient has sufficient oestradiol, withdrawal bleeding should occur - indicating that the patients amenorrhoea is due to anovulation
if no bleeding occurs it is likely to be due to low serum oestradiol, HPA dysfunction etc
progesterone challenge test in WHO group 1 anovulation
negative
WHO group 2 definition of anovulation
hypothalamic pituitary dysfunction
- normal gonadotrophins/excess LH
- normal eostrogen levels - positive progesterone test
- oligo/amenorrhoea
PCOS
WHO group 3 definition of anovulation
ovarian failure
which WHO group of anovulation is PCOS classified into
2
premature ovarian failure
amenorrhoea, oestrogen deficiency and elevated gonadotrophins occuring <40 as a result of loss of ovarian function
there is a low likelihood of conception
biochemistry of premature ovarian failure
FSH >30 on 2 separate occasions more than one month apart
LH high
oestradiol low
causes of premature ovarian failure
autoimmune disease (eg associations with Addison’s, thyroid, APS1/2)
chromosomal abnormalities (e.g. Turner, Fragile X, XX gonadal agenesis)
gene mutations (eg in FSH/LH receptor)
iatrogenic - radio/chemo, bilateral oophorectomy
clinical features of premature ovarian failure
features of low oestrogen:
hot flushes
night sweats
atrophic vaginitis
treatment of premature ovarian failure
hormone replacement therapy
egg/embryo donation
counselling and support networks
secondary hypogonadism
hypogonadism as a result of hypothalamic or pituitary disease
characterised by low oestradiol and low/inappropriately normal LH and FSH
causes of secondary hypogonadism
hypothalamic problems:
- functional disorders: low weight (BMI <18.5), stress, extreme exercise)
- brain pituitary tumours
- Kallman’s syndrome
- IHH
pitutiary problems
miscellaneous: Prader/Willi and haemachromatosis
management of hypothalamic anovulation
- stabilise weight
- BMI >18.5
- pulsatile GnRH if hypog hypog
- -SC/IV, pulsatile administration every 90 minutes
- LH and FSH daily injections
- require US monitoring of response
what is the problem with gonadotrophin injections to treat secondary hypogonadism
higher multiple pregnancy rates
what is the ovulation rate with pulsatile GnRH treatment for secondary hypogonadism
90%
what are the 3 types of functional hypothalamic amenorrhoea
weight change
stress
extreme exercise
why does stress cause amenorrhoea
evolutionary mechanism to avoid conception during physiological stress
at which BMI does amenorrhoea tend to occur
<18.5 normal ovulatory cycle unlikely
<16 cycle usually stops
what happens to GnRH secretion in functional hypothalamic amenorrhoea
aberrations in pulsatile GnRH secretion, causes impairement of LH and FSH
there are complex hormonal changes manifested by profound hypooestrogenism
idiopathic hypogonadotrophic hypogonadism
- congenital absent/delayed sexual development associated with inappropriate low levels of gonadotrophic and sex hormones in the absence of anatomical/functional defects of HPA
- major defect is an inability to activate pulsatile GnRH secretion during puberty due to a genetic defect
what additional phenotype features may be present in IHH
anosmia
what mutations have been identified as a cause of IHH
mutations in GPCR KISS1R (GPR54) gene
the ligand for KISS1R - ‘Kisspeptin’ is a potent stimulator of GnRH secretion
GnRH neurone has Kisspeptin receptors on it, pulsatile release of Kisspeptin causes pulsatile release of FH and LSH
name 3 functions of Kisspeptin
gatekeeper of puberty and GnRH secretion
key regulator of male and female fertility
influence positive and negative feedback of oestrogen and therefore influence ovulation and menstrual cycle
what are most of IHH cases
60% kallman’s syndrome
40% normosmic IHH